Mechanisms of spontaneous and glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma

S. V. Boichuk, I. G. Mustafin, R. S. Fassachov (Kazan, Russia)

Source: Annual Congress 2001 - Asthma monitoring and therapy
Session: Asthma monitoring and therapy
Session type: Thematic Poster Session
Number: 1801
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. V. Boichuk, I. G. Mustafin, R. S. Fassachov (Kazan, Russia). Mechanisms of spontaneous and glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma. Eur Respir J 2001; 16: Suppl. 31, 1801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The mechanisms of glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma (ABA)
Source: Eur Respir J 2002; 20: Suppl. 38, 29s
Year: 2002

Lymphocyte apoptosis in atopic bronchial asthma: the mechanisms, role in pathogenesis and therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

The abnormalities in spontaneous and Fas-induced apoptosis in atopic bronchial asthma (ABA): the key to chronic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006

Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


The influence of topical glucocorticoid on apoptosis of lymphocytes during allergic rhinitis
Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Year: 2008


Spontaneous, Fas- and glucocorticoid (GC)-mediated lymphocyte apoptosis in atopic bronchial asthma(ABA): mechanisms, role in pathogenesis and therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

Mechanisms of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009



Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 433s
Year: 2006

Cytokine regulation of the chronicle inflammation of bronchial asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005

Variants of allergic response in children with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Association between eosinophilic airway inflammation and T-cells response in children with bronchial asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010


Airways inflammation is related to bronchial responsiveness only in atopic subjects with rhinitis and/or asthma
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008

In situ proliferation of bronchial T-cells in asthma
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

Relationship between allergen-induced increase of AHR to bradykinin, expression of the proliferation marker Ki-67 and eosinophils in bronchial mucosa of atopic asthmatics
Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways
Year: 2003


Basophil surface antigens in bronchial asthma and allergic rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

Airway inflammation and lung function in atopic and non-atopic rhinitis
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018

Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010